Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Axonics, Inc.

< Previous 1 2 Next >
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Prevails in Patent Infringement Lawsuit with Medtronic
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Reports Second Quarter 2024 Financial Results
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Reports First Quarter 2024 Financial Results
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Stockholders Approve Merger Agreement with Boston Scientific
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Responds to ITC Action by Medtronic
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
From Axonics, Inc.
Via Business Wire
Tickers AXNX BSX
Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics to Present at the J.P. Morgan Healthcare Conference
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics to Participate in November Investor Conferences
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Reports Third Quarter 2023 Financial Results
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics to Report Third Quarter 2023 Financial Results on October 30
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics to Participate in September Investor Conferences
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Announces CFO Retirement and Appoints Successor
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Reports Second Quarter 2023 Financial Results
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics to Report Second Quarter 2023 Financial Results on July 27
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Reports First Quarter 2023 Financial Results
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics to Participate in Upcoming Investor Conferences
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics to Report First Quarter 2023 Financial Results on May 1
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Ranked No. 2 on the Financial Times 2023 List of the Fastest Growing Companies in the Americas
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics to Participate in the SUFU 2023 Winter Meeting
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Reports Fourth Quarter and Fiscal Year 2022 Financial Results
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics to Report Fourth Quarter 2022 Financial Results on March 1
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics Reports Preliminary Fiscal Year 2022 Revenue and Provides Fiscal Year 2023 Revenue Guidance
From Axonics, Inc.
Via Business Wire
Tickers AXNX
Axonics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Axonics, Inc.
Via Business Wire
Tickers AXNX
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.